Price equation captures the role of drug interactions and collateral effects in the evolution of multidrug resistance by Erida Gjini, Kevin B Wood

Subjects: Get full text

Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications by Thiago de Lima Pessoa, Washington Sales Clemente Junior, Tatiana Xavier da Costa, Priscilla Karilline do Vale Bezerra, Rand Randall Martins

“…The drug interactions were classified by type, prevalence and exposure rate. …”
Get full text

Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers by Hae Won Lee, Woo Youl Kang, Wookjae Jung, Mi-Ri Gwon, Kyunghee Cho, Dong Heon Yang, Young-Ran Yoon, Sook Jin Seong

Subjects: Get full text

The Frequency of Drug Interactions in Patients in the Intensive Care Units of Alzahra Hospital, Isfahan, Iran by Parviz Kashefi, Sara Mousavi, Ali Hosseini

Subjects: “…Drug interactions…”
Get full text

Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients by Jiali Zhang, Danyi Ma, Meng Chen, Yanting Hu, Xveying Chen, Jingyu Chen, Man Huang, Haibin Dai

Subjects: “…potential drug-drug interactions…”
Get full text

Investigation of Drug-Interaction Potential for Arthritis Dietary Supplements: Chondroitin Sulfate, Glucosamine, and Methylsulfonylmethane by Su Min Kim, So Young Jo, Ho-Young Park, Yu Ra Lee, Jun Sang Yu, Hye Hyun Yoo

“…However, given the previous reports of interaction cases involving glucosamine, caution is advised regarding dietary supplement–drug interactions.…”
Get full text

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice by Nicola Ferri, Elisa Colombo, Marco Tenconi, Ludovico Baldessin, Alberto Corsini

Subjects: Get full text

Usability in Patient-Oriented Drug Interaction Checkers—A Scandinavian Sampling and Heuristic Evaluation by David Vingen, Elias J. Andrews, Mexhid Ferati

Subjects: Get full text

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy by Paula Bachmann, Niklas Frahm, Jane Louisa Debus, Pegah Mashhadiakbar, Silvan Elias Langhorst, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Michael Hecker, Uwe Klaus Zettl

Subjects: Get full text

<i>In Vitro</i> Hepatic Models to Assess Herb–Drug Interactions: Approaches and Challenges by Hlengwa N., Masilela C., Mtambo T. R., Sithole S., Naidoo S., Machaba K. E., Shabalala S. C., Ntamo Y., Dludla P. V., Milase R. N.

Subjects: “…herb–drug interactions…”
Get full text

Drug-drug interaction with oral antivirals for early treatment of COVID-19 – Authors’ reply by Carsten Schade Larsen

Get full text

Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches by Yaru Peng, Zeneng Cheng, Feifan Xie

Subjects: “…drug–drug interactions…”
Get full text

A pilot metabolomic study of drug interaction with the immune response to seasonal influenza vaccination by Amnah Siddiqa, Yating Wang, Maheshwor Thapa, Dominique E. Martin, Andreia N. Cadar, Jenna M. Bartley, Shuzhao Li

“…This study demonstrates the concept of using metabolomics to investigate drug interaction with the immune response in human samples directly at molecular levels.…”
Get full text

Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data. by Kwang-Hee Shin, Young-Mi Ah, Sang Hun Cha, Hye Duck Choi

“…The aim of this study was to evaluate drug-drug interactions between docetaxel and coadministered medicines in patients with breast cancer a claims database. …”
Get full text

Drug Interactions With the Ca2+-ATPase From Sarco(Endo)Plasmic Reticulum (SERCA) by Francesco Tadini-Buoninsegni, Serena Smeazzetto, Roberta Gualdani, Maria Rosa Moncelli

Get full text

The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone by Qingqing Li, Jing Wang, Zheng-lu Wang, Yuxin Shen, Qi Zhou, Ya-nan Liu, Guo-xin Hu, Jian-ping Cai, Ren-ai Xu

“…The aim of this study was to investigate the impacts of 24 variants of recombinant human CYP3A4 and drug interactions on the metabolism of lurasidone. In vitro, enzymatic reaction incubation system of CYP3A4 was established to determine the kinetic parameters of lurasidone catalyzed by 24 CYP3A4 variants. …”
Get full text

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms by Ivan Krečak, Ljerka Pivac, Marko Lucijanić, Marko Skelin

Subjects: Get full text

Ascorbic Acid Ameliorates Cardiac and Hepatic Toxicity Induced by Azithromycin-Etoricoxib Drug Interaction by Reham Z. Hamza, Fatima S. Alaryani, Fatma Omara, Mahmoud A. A. Said, Sayed A. Abd El-Aziz, Sawsan M. El-Sheikh

“…Due to the increased number of medications taken by patients, the potential for drug-drug interactions has clinically important consequences. …”
Get full text

Anticoagulant drug‐drug interactions: Highlighting the need for antithrombotic stewardship and shared decision making by Sara R. Vazquez, Geoffrey D. Barnes

Get full text

Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis by Selçuk Şen, Eda Karahan, Cansu Büyükulaş, Yasin Onur Polat, Ali Yağız Üresin

Get full text